AI in Medicine News ・ 💊 Drug discovery and clinical trials

Insilico Medicine and Servier Achieve First Milestone in AI-Driven R&D Collaboration, Triggering An undisclosed Milestone Payment

Insilico Medicine · 10/19 16:00 UTC

Insilico Medicine (HKEX: 3696), a clinical-stage generative AI-driven drug discovery company, announced it has achieved the early drug discovery milestone in its multi-year collaboration with Servier. Servier is an independent international pharmaceutical group governed by a foundation.

Read the original (Insilico Medicine)

See it in the digest → ・ See this issue →